ACCESSION: MSBNK-SMB_Measured-HSA015P0200011
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 20
COMMENT: RAW_SPEC {'EL08_pos_9711': {'bp': 142289.0, 'sum': 639769.0}, 'EL11_pos_9886': {'bp': 83988.0, 'sum': 456224.0}, 'Blanc2-pos_9796': {'bp': 85846.0, 'sum': 446537.0}, 'EL05_pos_9970': {'bp': 88174.0, 'sum': 487352.0}, 'EL13_pos_9922': {'bp': 87613.0, 'sum': 445540.0}, 'EL20_pos_9899': {'bp': 102381.0, 'sum': 483121.0}, 'EL15_pos_9941': {'bp': 98862.0, 'sum': 490301.0}, 'EL21_pos_9908': {'bp': 100284.0, 'sum': 528360.0}, 'Blanc3-pos_9838': {'bp': 80073.0, 'sum': 431775.0}, 'EL02_pos_9983': {'bp': 95116.0, 'sum': 504492.0}, 'EL22_pos_10001': {'bp': 101629.0, 'sum': 568479.0}, 'EL12_pos_9953': {'bp': 99019.0, 'sum': 501293.0}, 'EL10_pos_9898': {'bp': 99004.0, 'sum': 461308.0}, 'EL01_pos_9898': {'bp': 89960.0, 'sum': 438158.0}, 'EL09_pos_9910': {'bp': 85567.0, 'sum': 430890.0}, 'EL24_pos_9904': {'bp': 88269.0, 'sum': 417433.0}, 'EL07_pos_9892': {'bp': 92677.0, 'sum': 499323.0}, 'EL08_pos_9880': {'bp': 95311.0, 'sum': 457327.0}, 'EL23_pos_9899': {'bp': 93969.0, 'sum': 426307.0}, 'EL14_pos_9929': {'bp': 90656.0, 'sum': 420088.0}}
COMMENT: RETENTION_TIME_STDEV 0.071
COMMENT: PRECURSOR_M/Z_RAW 200.201049
COMMENT: PRECURSOR_M/Z_STDEV 0.000072
COMMENT: PRECURSOR_IN_MS1 mz 200.200821; int 33.062; delta(ppm) 1.104558
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.361; C12H25NO; [M+H]+; delta(ppm) -0.361458
COMMENT: PROPOSED_MF MS-FINDER 3.428; C12H25NO; [M+H]+; delta(ppm) -0.363928
COMMENT: PROPOSED_MF SIRIUS5_Sirius 12.104; C12H25NO; [M+H]+; delta(ppm) -0.363928
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C12H25NO; [M+H]+; delta(ppm) -0.363928
COMMENT: PROPOSED_MF SIRIUS6_Sirius 14.305; C12H25NO; [M+H]+; delta(ppm) -0.363928
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.444; C10H23N4; [M+H]+; delta(ppm) 6.342696
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C12H25NO; [M+H]+; delta(ppm) -0.363928
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.368; UXJMDSSXCNYLKF-UHFFFAOYSA-N; [M+H]+; O=C(NCC(C)C)CCCCCCC
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.280; PDIAUMAGVLKNQE-UHFFFAOYSA-N; [M+H]+; O1CCC(CNCC(C)C)CC1(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.183; HNXNKTMIVROLTK-UHFFFAOYSA-N; [M+H]+; CCCCCCCCCC(=O)N(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.148; GKHOHOBTPPHISC-UHFFFAOYSA-N; [M+H]+; ON=CCCCCCCCCCCC
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.145; FFKFZVBZDLZVDJ-UHFFFAOYSA-N; [M+H]+; O1CCC(CCN)(CCC)CC1(C)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.324; ILRSCQWREDREME-UHFFFAOYSA-N; [M+H]+; Dodecanamide;Lauroyl amide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.168; DYBRAHBPARLKOA-WEUYFXHZNA-N; [M+H]+; Halaminol B;(+)-Halaminol B
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.115; HNXNKTMIVROLTK-UHFFFAOYSA-N; [M+H]+; N,N-dimethyldecan-1-amide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.115; ALEPIEAQGFDQEN-QHOHXRKFNA-N; [M+H]+; UNPD127771
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.063; FFKFZVBZDLZVDJ-UHFFFAOYSA-N; [M+H]+; 2-(2,2-dimethyl-4-propyloxan-4-yl)ethan-1-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.063; GKHOHOBTPPHISC-UHFFFAOYSA-N; [M+H]+; N-dodecylidenehydroxylamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.063; GNYKHQJGTQHNQT-UHFFFAOYSA-N; [M+H]+; CNP0432549
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.063; PDIAUMAGVLKNQE-UHFFFAOYSA-N; [M+H]+; [(2,2-dimethyloxan-4-yl)methyl](2-methylpropyl)amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.063; UXJMDSSXCNYLKF-UHFFFAOYSA-N; [M+H]+; N-(2-methylpropyl)octanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; PDIAUMAGVLKNQE-UHFFFAOYSA-N; [M+H]+; [(2,2-dimethyloxan-4-yl)methyl](2-methylpropyl)amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.684; DYBRAHBPARLKOA-WEUYFXHZNA-N; [M+H]+; Halaminol B;(+)-Halaminol B
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.684; ALEPIEAQGFDQEN-QHOHXRKFNA-N; [M+H]+; UNPD127771
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; ILRSCQWREDREME-UHFFFAOYSA-N; [M+H]+; Dodecanamide;Lauroyl amide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; HNXNKTMIVROLTK-UHFFFAOYSA-N; [M+H]+; N,N-dimethyldecan-1-amide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; FFKFZVBZDLZVDJ-UHFFFAOYSA-N; [M+H]+; 2-(2,2-dimethyl-4-propyloxan-4-yl)ethan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; GKHOHOBTPPHISC-UHFFFAOYSA-N; [M+H]+; N-dodecylidenehydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; GNYKHQJGTQHNQT-UHFFFAOYSA-N; [M+H]+; CNP0432549
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; UXJMDSSXCNYLKF-UHFFFAOYSA-N; [M+H]+; N-(2-methylpropyl)octanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.750; ILRSCQWREDREME-UHFFFAOYSA-N; [M+H]+; dodecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.515; FHJRFIYKPIXQNQ-UHFFFAOYSA-N; [M+H]+; N,N-diethyloctanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.500; LYGCLXFQIQORSE-UHFFFAOYSA-N; [M+H]+; N,N,2-triethylhexanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.250; KYZCGAYOKKRLFZ-UHFFFAOYSA-N; [M+H]+; N,N-diethyl-2-propylpentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.066; HNXNKTMIVROLTK-UHFFFAOYSA-N; [M+H]+; N,N-dimethyldecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.972; KYDLJIHLGZYOCL-UHFFFAOYSA-N; [M+H]+; 2-[butan-2-yl(cyclohexyl)amino]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.972; MBESFWFEAFNCAI-UHFFFAOYSA-N; [M+H]+; 1-(dibutylamino)but-3-en-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.764; PCOMMNVANAQDMV-UHFFFAOYSA-N; [M+H]+; N,2-diethyl-3-methyl-2-propan-2-ylbutanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.255; DXFXMYYJKFIEGI-UHFFFAOYSA-N; [M+H]+; N-decylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.253; GKHOHOBTPPHISC-OUKQBFOZSA-N; [M+H]+; (NE)-N-dodecylidenehydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.251; GUDYPJBECYDZAH-UHFFFAOYSA-N; [M+H]+; N-pentylheptanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.250; PAUJKVQAWLQVGZ-UHFFFAOYSA-N; [M+H]+; N-butyl-2-ethylhexanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.250; XENQEFYNRCVZDN-UHFFFAOYSA-N; [M+H]+; N-butyl-2-propylpentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.250; ZBUDHVXAJJWVIL-UHFFFAOYSA-N; [M+H]+; 3-(dimethylamino)-2,2-diethyl-4,4-dimethylcyclobutan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.250; OKLSRFBLQYAVGR-UHFFFAOYSA-N; [M+H]+; N-tert-butyl-2-propylpentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.250; NYNDHQLCFINTDP-UHFFFAOYSA-N; [M+H]+; N-(2-methylpropyl)-2-propylpentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.250; YJEXLVQMCUHSKZ-UHFFFAOYSA-N; [M+H]+; 2-methyl-6-pyrrolidin-1-ylheptan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.250; PVWKAVAGRAOIDO-UHFFFAOYSA-N; [M+H]+; N-(3-propylhexan-2-yl)propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.250; LYUWNWKLTCEFLV-UHFFFAOYSA-N; [M+H]+; N-ethyl-N-(2-propylpentyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.250; STLPPPYZHTZUCZ-UHFFFAOYSA-N; [M+H]+; 2,3-dipropylhexanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.250; OVFGBHWGBAWIOV-UHFFFAOYSA-N; [M+H]+; (1-methoxy-3,3,5,5-tetramethylcyclohexyl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -61.235; DXFXMYYJKFIEGI; [M+H]+; N-Decylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -61.243; UXJMDSSXCNYLKF; [M+H]+; n-(2-methylpropyl)octanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -67.032; FHJRFIYKPIXQNQ; [M+H]+; N,N-Diethyloctamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -76.543; GUDYPJBECYDZAH; [M+H]+; N-Pentylheptanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -80.767; ILRSCQWREDREME; [M+H]+; Amide KK
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -88.114; LYGCLXFQIQORSE; [M+H]+; N,N-2-Triethylhexamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -95.980; KYZCGAYOKKRLFZ; [M+H]+; N,N-Diethyl-2-propylvaleramide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -97.836; NYNDHQLCFINTDP; [M+H]+; N-Isobutyl-2-propylvaleramide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -99.071; LYUWNWKLTCEFLV; [M+H]+; N-Ethyl N-propyl-2 pentylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -103.691; NBESHLYYMHCQHT; [M+H]+; N-Ethyl-2-isopropyl-2-methylhexanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -104.527; HNXNKTMIVROLTK; [M+H]+; N,N-Dimethylcapramide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -107.019; GKHOHOBTPPHISC; [M+H]+; Dodecyl aldoxime
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -107.248; TXZSLZLHRVGMMP; [M+H]+; N-Ethyl-2-isopropyl-2,4-dimethylvaleramide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -108.152; PAUJKVQAWLQVGZ; [M+H]+; N-Butyl-2-ethylhexanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -117.858; PCOMMNVANAQDMV; [M+H]+; Butanamide,N-ethyl-2,2-bis(1-methylethyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -122.998; STLPPPYZHTZUCZ; [M+H]+; 2,3-Dipropylhexanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -124.124; XENQEFYNRCVZDN; [M+H]+; N-Butyl-2-propylvaleramide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -131.256; QBXUVIKBDIUBIU; [M+H]+; 10-methylundecanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -137.987; QVCDGEQFSCTPBS; [M+H]+; 2-sec-Butyl-N-ethyl-4-methylvaleramide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -154.218; WGRZDAWYLITYAD; [M+H]+; n,2-diisopropyl-2,3-dimethylbutanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -161.191; RNTPPLUFUHIOOM; [M+H]+; 2-Isopropyl-N,N,2-trimethylhexanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -162.109; NMLNNXGEQCSYGQ; [M+H]+; 4-Octylmorpholine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -170.978; PVWKAVAGRAOIDO; [M+H]+; N-(3-propylhexan-2-yl)propanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -212.811; OKLSRFBLQYAVGR; [M+H]+; N-tert-Butyl-2-propylvaleramide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -214.996; YJEXLVQMCUHSKZ; [M+H]+; 2-methyl-6-pyrrolidin-1-ylheptan-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -233.584; MBESFWFEAFNCAI; [M+H]+; 1-(dibutylamino)but-3-en-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -238.434; PDIAUMAGVLKNQE; [M+H]+; N-[(2,2-dimethyloxan-4-yl)methyl]-2-methylpropan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -244.218; ALEPIEAQGFDQEN; [M+H]+; (2R,3S)-Clavaminol B
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -276.654; GNYKHQJGTQHNQT; [M+H]+; 2-(methylamino)-1-(1,2,2,3-tetramethylcyclopentyl)ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -278.965; DYBRAHBPARLKOA; [M+H]+; Halaminol B
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -284.040; ZBUDHVXAJJWVIL; [M+H]+; 3-(Dimethylamino)-2,2-diethyl-4,4-dimethylcyclobutanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -296.834; FFKFZVBZDLZVDJ; [M+H]+; 2-(2,2-dimethyl-4-propyltetrahydro-2H-pyran-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.119; DXFXMYYJKFIEGI; [M+H]+; N-Decylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -126.729; LYGCLXFQIQORSE; [M+H]+; N,N,2-Triethylhexanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -127.508; KYZCGAYOKKRLFZ; [M+H]+; Valeramide, N,N-diethyl-2-propyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -181.394; FHJRFIYKPIXQNQ; [M+H]+; N,N-Diethyloctanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -185.223; LYUWNWKLTCEFLV; [M+H]+; Acetamide, N-ethyl-N-(2-propylpentyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -196.077; PAUJKVQAWLQVGZ; [M+H]+; N-Butyl-2-ethylhexanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -202.514; GKHOHOBTPPHISC; [M+H]+; N-dodecylidenehydroxylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -202.705; XENQEFYNRCVZDN; [M+H]+; Valeramide, N-butyl-2-propyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -211.811; NYNDHQLCFINTDP; [M+H]+; Valeramide, N-isobutyl-2-propyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -227.805; STLPPPYZHTZUCZ; [M+H]+; 2,3-Dipropylhexanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -231.372; OKLSRFBLQYAVGR; [M+H]+; Valeramide, N-tert-butyl-2-propyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.612; LYGCLXFQIQORSE; [M+H]+; N,N,2-Triethylhexanamide
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C12H26N1O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 16.125
MS$FOCUSED_ION: PRECURSOR_M/Z 200.200818
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0uk9-9440000000-7de2e457b54fa4defc90
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0544996 110.1970 55.055207 1.1080 13.02 0.3474 19 f{C4H7}/4.96ppm,p-C8H19N1O1
  55.9346638 161.1553 55.935375 0.7866 32.09 0.0376 20 ?
  57.0701460 215.9782 57.070862 0.5081 17.42 0.3248 20 f{C4H9}/4.72ppm,p-C8H17N1O1
  60.0446196 85.1054 60.045347 1.0492 35.34 0.0357 15 f{C2H6N1O1}/3.82ppm,p-C10H20
  69.0699858 58.3112 69.070729 0.7529 12.11 0.4902 17 f{C5H9}/1.58ppm,p-C7H17N1O1
  70.9579921 25.5334 70.958735 1.1556 6.83 0.3143 15 ?
  71.0493001 27.6768 71.050043 1.4919 5.34 0.4500 15 f{C4H7O1}/2.24ppm,p-C8H19N1
  71.0856224 47.4279 71.086366 1.1817 10.24 0.3127 18 f{C5H11}/1.35ppm,p-C7H15N1O1
  72.0445336 96.3743 72.045276 1.2492 18.02 0.0586 20 f{C3H6N1O1}/1.99ppm,p-C9H20
  72.9371781 71.6648 72.937921 0.9597 12.90 0.1534 20 ?
  74.0601155 44.5756 74.060857 1.0262 13.42 0.1684 19 f{C3H8N1O1}/1.02ppm,p-C9H18
  74.0965362 714.0529 74.097278 0.3239 94.29 0.5368 20 f{C4H12N1}/1.49ppm,p-C8H14O1
  75.0998267 28.7281 75.100567 1.2250 7.67 0.1071 15 ?
  81.0698580 37.4723 81.070584 1.2705 8.03 0.5059 16 f{C6H9}/-0.23ppm,p-C6H17N1O1
  83.0855795 86.2077 83.086299 1.2156 13.32 0.5193 19 f{C6H11}/0.63ppm,p-C6H15N1O1
  88.0757202 161.8411 88.076417 0.7380 26.54 0.4737 20 f{C4H10N1O1}/0.34ppm,p-C8H16
  88.9684016 48.5963 88.969093 1.3825 11.44 0.1248 20 ?
  90.9476152 30.0348 90.948296 1.4624 8.22 0.4881 18 ?
  95.0854720 33.0621 95.086124 1.4934 8.09 0.1235 16 f{C7H11}/-0.58ppm,p-C5H15N1O1
  100.0757241 203.9390 100.076336 0.5696 31.55 0.4662 20 f{C5H10N1O1}/0.34ppm,p-C7H16
  102.0913291 93.0746 102.091922 1.1950 14.81 0.2180 20 f{C5H12N1O1}/-0.11ppm,p-C7H14
  107.9504384 29.8074 107.950975 1.8342 8.74 0.0882 16 ?
  114.0549058 40.1818 114.055397 1.0434 9.10 0.3260 17 ?
  116.1070185 29.9562 116.107493 1.5158 6.13 0.4500 15 f{C6H14N1O1}/0.24ppm,p-C6H12
  128.9508328 226.3449 128.951179 0.7988 19.70 0.5158 20 ?
  131.9741803 39.1696 131.974492 1.3563 15.59 0.1887 17 ?
  135.9453482 69.2877 135.945612 1.1034 14.32 0.2797 20 ?
  146.9613496 109.0504 146.961642 1.3337 14.46 0.2298 19 ?
  158.9613145 65.5562 158.961640 1.2707 12.67 -0.0070 19 ?
  198.1853834 45.1905 198.185827 1.5844 8.74 0.7071 15 f{C12H24N1O1}/0.72ppm,p-H2
  199.1808278 174.3499 199.181274 1.2049 25.19 0.6836 19 ?
  200.2008653 999.0000 200.201314 0.4695 0.00 1.0000 20 f{C12H26N1O1}/-0.13ppm,p
  201.2042508 114.8700 201.204698 1.2077 10.95 0.5930 19 ?
PK$NUM_PEAK: 33
PK$PEAK: m/z int. rel.int.
  55.054500 110.20 110
  55.934664 161.16 161
  57.070146 215.98 215
  60.044620 85.11 85
  69.069986 58.31 58
  70.957992 25.53 25
  71.049300 27.68 27
  71.085622 47.43 47
  72.044534 96.37 96
  72.937178 71.66 71
  74.060115 44.58 44
  74.096536 714.05 714
  75.099827 28.73 28
  81.069858 37.47 37
  83.085580 86.21 86
  88.075720 161.84 161
  88.968402 48.60 48
  90.947615 30.03 30
  95.085472 33.06 33
  100.075724 203.94 203
  102.091329 93.07 93
  107.950438 29.81 29
  114.054906 40.18 40
  116.107018 29.96 29
  128.950833 226.34 226
  131.974180 39.17 39
  135.945348 69.29 69
  146.961350 109.05 109
  158.961314 65.56 65
  198.185383 45.19 45
  199.180828 174.35 174
  200.200865 999.00 999
  201.204251 114.87 114
//
